Return to search

Serentis Raises Series A

Serentis Inc., a UK drug startup formed by former Arakis Ltd. executives, has raised $20.47 million in Series A funding, according to a regulatory filing. Backers include Novo AS, MVM Life Science Partners and Apposite Capital. www.serentis-pharma.com